Single Dose ADME Study of [14C]SJP-0008 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 24, 2021

Primary Completion Date

November 2, 2021

Study Completion Date

November 2, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

[14C]SJP-0008

Single oral dose of \[14C\]SJP-0008

Trial Locations (1)

Quotient Sciences, Ruddington

All Listed Sponsors

collaborator

Quotient Sciences

INDUSTRY

lead

Senju Pharmaceutical Co., Ltd.

INDUSTRY

NCT05320861 - Single Dose ADME Study of [14C]SJP-0008 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter